1. Holick, MF (2007) Vitamin D deficiency. N Engl J Med 357, 266–281.
2. Trehan, N, Afonso, L, Levine, DL, et al. (2017) Vitamin D deficiency, supplementation, and cardiovascular health. Crit Pathw Cardiol 16, 109–118.
3. Holick, MF (2004) Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr 79, 362–371.
4. Lee, JH, O’Keefe, JH, Bell, D, et al. (2008) Vitamin D deficiency: an important, common, and easily treatable cardiovascular risk factor? J Am Coll Cardiol 5, 1949–1956.
5. Hirani, V, Mosdol, A & Mishra, G (2009) Predictors of 25-hydroxyvitamin D status among adults in two British national surveys. Br J Nutr 101, 760–764.
6. Judd, SE & Tangpricha, V (2009) Vitamin D deficiency and risk of cardiovascular disease. Am J Med Sci 338, 40–44.
7. Giovannucci, E, Liu, Y, Hollis, BW, et al. (2008) 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med 168, 1174–1180.
8. Dobnig, H, Pilz, S, Scharnagl, H, et al. (2008) Independent association of low serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality. Arch Intern Med 168, 1340–1349.
9. Freedman, DM, Looker, AC, Chang, SC, et al. (2007) Prospective study of serum vitamin D and cancer mortality in the United States. J Natl Cancer Inst 99, 1594–1602.
10. John, EM, Schwartz, GG, Dreon, DM, et al. (1999) Vitamin D and breast cancer risk: the NHANES I epidemiologic follow-up study, 1971–1975 to 1992: National Health and Nutrition Examination Survey. Cancer Epidemiol Biomarkers Prev 8, 399–406.
11. Zhao, XY & Feldman, D (2001) The role of vitamin D in prostate cancer. Steroids 66, 293–300.
12. Rostand, SG (1997) Ultraviolet light may contribute to geographic and racial blood pressure differences. Hypertension 30, 150–156.
13. Casteels, K, Waer, M, Bouillon, R, et al. (1998) 1,25-Dihydroxyvitamin D3 restores sensitivity to cyclophosphamide-induced apoptosis in nonobese diabetic (NOD) mice and protects against diabetes. Clin Exp Immunol 112, 181–187.
14. Munger, KL, Zhang, SM, O’Reilly, E, et al. (2004) Vitamin D intake and incidence of multiple sclerosis. Neurology 62, 60–65.
15. Merlino, LA, Curtis, J, Mikuls, TR, et al. (2004) Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Iowa Women’s Health Study. Arthritis Rheum 50, 72–77.
16. Holick, MF (2005) Vitamin D: important for prevention of osteoporosis, cardiovascular heart disease, type 1 diabetes, autoimmune diseases, and some cancers. South Med J 98, 1024–1027.
17. Cashman, KD, Dowling, KG, Sˇkraba ́kova, Z, et al. (2016) Vitamin D deficiency in Europe: pandemic? Am J Clin Nutr 103, 1033–1044.
18. Carrillo-Vega, MF, García-Peña, C, Gutiérrez-Robledo, LM, et al. (2017) Vitamin D deficiency in older adults and its associated factors: a cross-sectional analysis of the Mexican Health and Aging Study. Arch Osteoporos 12, 8.
19. Hirani, V, Cumming, RG, Blyth, FM, et al. (2013) Vitamin D status among older community dwelling men living in a sunny country and associations with lifestyle factors: the Concord Health and Ageing in Men Project, Sydney, Australia. J Nutr Health Aging 17, 587–593.
20. Gozdzik, A, Barta, JL, Wu, H, et al. (2008) Low wintertime vitamin D levels in a sample of healthy young adults of diverse ancestry living in the Toronto area: associations with vitamin D intake and skin pigmentation. BMC Public Health 8, 336.
21. Ross, AC, Manson, JE, Abrams, SA, et al. (2011) The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 96, 53–58.
22. Holick, MF, Binkley, NC, Bischoff-Ferrari, HA, et al. (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96, 1911–1930.
23. Holick, MF (2008) The vitamin D deficiency pandemic and consequences for nonskeletal health: mechanisms of action. Mol Aspects Med 29, 361–368.
24. Catherine, M., Gordon, CM, Feldman, HA, et al. (2008) Prevalence of vitamin D deficiency among healthy infants and toddlers. Arch Pediatr Adolesc Med 162, 505–512.
25. Gordon, CM, DePeter, KC, Feldman, HA, et al. (2004) Prevalence of vitamin D deficiency among healthy adolescents. Arch Pediatr Adolesc Med 158, 531–537.
26. Turer, CB, Lin, H & Flores, G (2013) Prevalence of vitamin d deficiency among overweight and obese US children. Pediatrics 131, e152–e161.
27. Freishtat, RJ, Iqbal, SF, Pillai, DK, et al. (2010) High prevalence of vitamin D deficiency among inner-city African American youth with asthma in Washington, DC. J Pediatr 156, 948–952.
28. Looker, AC, Johnson, CL, Lacher, DA, et al. (2011) Vitamin D Status: United States, 2001–2006. NCHS Data Brief, no 59. Hyattsville, MD: National Center for Health Statistics.
29. Looker, AC, Pfeiffer, CM, Lacher, DA, et al. (2008) Serum 25-hydroxyvitamin D status of the US population: 1988–1994 compared with 2000–2004. Am J Clin Nutr 88, 1519–1527.
30. Bischoff-Ferrari, HA, Willett, WC, Wong, JB, et al. (2009) Prevention of nonvertebral fractures with oral vitamin D and dose dependency: a meta-analysis of randomized controlled trials. Arch Intern Med 169, 551–561.
31. Bischoff-Ferrari, HA, Dietrich, T, Orav, EJ, et al. (2004) Positive association between 25-hydroxy vitamin D levels and bone mineral density: a population-based study of younger and older adults. Am J Med 116, 634–639.
32. National Center for Health Statistics in the Centers for Disease Control and Prevention (2013) National Health and Nutrition Examination Survey. http://www.cdc.gov/nchs/nhanes.htm (accessed February 2013).
33. Liu, XF & Duan, FF (2013) Prevalence of isolated systolic hypertension in Mexican Americans and other Hispanics. Am J Hypertens Res 1, 6–12.
34. Schleicher, RL, Sternberg, MR, Lacher, DA, et al. (2016) A method-bridging study for serum 25-hydroxyvitamin D to standardize historical radioimmunoassay data to liquid chromatography-tandem mass spectrometry. Natl Health Stat Report 93, 1–16.
35. Al-khalidi, B, Kimball, SM, Rotondi, MA, et al. (2017) Standardized serum 25-hydroxyvitamin D concentrations are inversely associated with cardiometabolic disease in U.S. adults: a cross-sectional analysis of NHANES, 2001–2010. Nutr J 16, 16.
36. Forrest, KYZ & Stuhldreher, WL (2011) Prevalence and correlates of vitamin D deficiency in US adults. Nutr Res 31, 48–54.
37. Calvo, MS, Whiting, SJ & Barton, CN (2004) Vitamin D fortification in the United States and Canada: current status and data needs. Am J Clin Nutr 80, 1710S–1716S.
38. Zadshir, A, Tareen, N, Pan, D, et al. (2005) The prevalence of hypovitaminosis D among US adults: data from the NHANES III. Ethn Dis 15, Suppl. 5, 97–101.
39. Araujo, AB, Travison, TG, Esche, GR, et al. (2009) Serum 25-hydroxyvitamin D and bone mineral density among Hispanic men. Osteoporos Int 20, 245–255.
40. Wortsman, J, Matsuoka, LY, Chen, TC, et al. (2000) Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 72, 690–693.
41. Vimaleswaran, KS, Berry, DJ, Liu, C, et al. (2013) Causal relationship between obesity and vitamin D status: bi-directional Mendelian randomization analysis of multiple cohorts. PLoS Med 10, e1001383.
43. Hansdottir, S, Monick, MM, Lovan, N., et al. (2010) Smoking disrupts vitamin D metabolism in the lungs [abstract]. Am J Respir Crit Care Med 181, A1425.
44. Brot, C, Jorgensen, NR & Sorensen, OH (1999) The influence of smoking on vitamin D status and calcium metabolism. Eur J Clin Nutr 53, 920–926.
45. Jo, YH, Talmage, DA & Role, LW (2002) Nicotinic receptor-mediated effects on appetite and food intake. J Neurobiol 53, 618–632.
46. Wijnia, JW, Wielders, JPM, Lips, P, et al. (2013) Is vitamin D deficiency a confounder in alcoholic skeletal muscle myopathy? Alcohol Clin Exp Res 37, E209–E215.